Feifei Nan
-
- Lymphoma Diagnosis and Treatment 26
- Oncology top 5%
- CAR-T cell therapy research 7
- Viral-associated cancers and disorders 6
- Cancer-related Molecular Pathways 3
- Immunology top 10%
- Immune Cell Function and Interaction 8
- T-cell and Retrovirus Studies 3
-
- Chronic Lymphocytic Leukemia Research 4
-
- CNS Lymphoma Diagnosis and Treatment 5
- Co-authors
- Yu ChangZhaoming LiXiaorui FuHuanle ZhangJingjing WuLei ZhangZhenchang SunXinhua Wang
- Partner nations
- ChinaUnited States
In The Last Decade
Feifei Nan
38 papers receiving 789 citations
Peers
Comparison fields: 5 of 67
- Pathology and Forensic Medicine 399
- Oncology 465
- Immunology 275
- Cancer Research 137
- Genetics 78
Countries citing papers authored by Feifei Nan
This map shows the geographic impact of Feifei Nan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Nan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Nan more than expected).
Fields of papers citing papers by Feifei Nan
This network shows the impact of papers produced by Feifei Nan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Nan. The network helps show where Feifei Nan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Feifei Nan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2022 | 1 | |
| 3 | 2021 | 2 | |
| 4 | 2021 | 2 | |
| 5 | 2020 | 10 | |
| 6 | 2020 | 11 | |
| 7 | 2020 | 10 | |
| 8 | 2020 | 7 | |
| 9 | 2019 | 7 | |
| 10 | 2018 | 5 | |
| 11 | 2018 | 18 | |
| 12 | 2017 | 2 | |
| 13 | 2017 | 21 | |
| 14 | 2017 | 14 | |
| 15 | 2016 | 3 | |
| 16 | 2015 | 11 | |
| 17 | 2015 | 15 | |
| 18 | 2013 | 31 | |
| 19 | 2010 | 69 | |
| 20 | 2010 | 93 |
About Feifei Nan
Feifei Nan is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics, having authored 38 papers that have together received 794 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (26 papers), Immune Cell Function and Interaction (8 papers), CAR-T cell therapy research (7 papers), Viral-associated cancers and disorders (6 papers), CNS Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), T-cell and Retrovirus Studies (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (399 citations), Oncology (465 citations) and Immunology (275 citations). Feifei Nan has collaborated with scholars based in China and United States. Frequent co-authors include Yu Chang, Zhaoming Li, Xiaorui Fu, Huanle Zhang, Jingjing Wu, Lei Zhang, Zhenchang Sun, Xinhua Wang, Mingzhu Huang and Jiaqin Yan. Their work appears in journals such as Leukemia Research, Oncotarget, Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.